These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

49 related items for PubMed ID: 1358326

  • 1. C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.
    Juang JH, Huang HS, Huang MJ.
    J Formos Med Assoc; 1992 May; 91(5):491-6. PubMed ID: 1358326
    [Abstract] [Full Text] [Related]

  • 2. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y, Kondo K, Hasegawa H, Oiso Y.
    Diabetes Res; 1994 May; 25(3):129-37. PubMed ID: 7671552
    [Abstract] [Full Text] [Related]

  • 3. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [Abstract] [Full Text] [Related]

  • 4. C-peptide response to glucagon in young diabetics.
    Juang JH, Huang BY, Huang HS, Lin JD, Huang MJ.
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD, Iwamoto Y, Matsuda A, Kuzuya T.
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influence of exogenous insulin on C-peptide levels in subjects with type 2 diabetes.
    Albareda M, Rigla M, Rodríguez-Espinosa J, Caballero A, Chico A, Cabezas R, Carreras G, Pérez A.
    Diabetes Res Clin Pract; 2005 Jun; 68(3):202-6. PubMed ID: 15936461
    [Abstract] [Full Text] [Related]

  • 10. Severity of liver echogenicity is correlated to serum c-peptide levels in type 2 diabetic patients.
    Papanas N, Symeonidis G, Mavridis G, Papazoglou D, Giannakis I, Papatheodorou K, Pastore F, Lakasas G, Maltezos E.
    Acta Clin Belg; 2006 Jun; 61(1):5-9. PubMed ID: 16673610
    [Abstract] [Full Text] [Related]

  • 11. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH.
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [Abstract] [Full Text] [Related]

  • 12. Plasma C-peptide and insulin responses to intravenous glucagon stimulation in idiopathic haemochromatosis.
    Rumbak MJ, Joffe BI, Seftel HC, Kalk WJ, Bezwoda WR, Bothwell TH.
    S Afr Med J; 1987 Mar 21; 71(6):351-3. PubMed ID: 3551126
    [Abstract] [Full Text] [Related]

  • 13. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
    Kan Y, Chi Z.
    Zhonghua Yi Xue Za Zhi; 1991 Jan 21; 71(1):16-7, 4. PubMed ID: 1850647
    [Abstract] [Full Text] [Related]

  • 14. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J, Patterson S, O'Harte FP, Bell PM.
    Metabolism; 2011 Jan 21; 60(1):52-6. PubMed ID: 20152998
    [Abstract] [Full Text] [Related]

  • 15. Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients.
    Vilsbøll T, Krarup T, Madsbad S, Holst JJ.
    Diabetologia; 2002 Aug 21; 45(8):1111-9. PubMed ID: 12189441
    [Abstract] [Full Text] [Related]

  • 16. The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.
    Bi Y, Tong GY, Yang HJ, Cai MY, Ma JH, Liang J, Xin B, Miao H, Peng ZH, Zhu DL.
    Diabetes Metab Res Rev; 2013 Nov 21; 29(8):664-72. PubMed ID: 23955995
    [Abstract] [Full Text] [Related]

  • 17. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK, Heding LG, Czyzyk A, Malczewski B, Królewski AS.
    Horm Metab Res; 1982 Mar 21; 14(3):112-6. PubMed ID: 7040196
    [Abstract] [Full Text] [Related]

  • 18. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
    Llorente I, Goñi MJ, Forga L, Monreal M, Lizcano F, Moncada E.
    Rev Med Univ Navarra; 1992 Mar 21; 37(1):25-9. PubMed ID: 1626165
    [Abstract] [Full Text] [Related]

  • 19. Relevance of beta-cell function for improved glycemic control after gastric bypass surgery.
    Blanco J, Jiménez A, Casamitjana R, Flores L, Lacy A, Conget I, Vidal J.
    Surg Obes Relat Dis; 2014 Mar 21; 10(1):9-13; quiz 189-90. PubMed ID: 24342036
    [Abstract] [Full Text] [Related]

  • 20. Effects of insulin therapy on non-insulin-dependent diabetics with secondary oral hypoglycemic agent failure.
    Peng YS, Juang JH.
    Changgeng Yi Xue Za Zhi; 1998 Sep 21; 21(3):271-6. PubMed ID: 9849007
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.